Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $102.00 at Robert W. Baird
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) had its target price raised by analysts at Robert W. Baird from $72.00 to $102.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s price objective would suggest a potential upside of 41.69% from the company’s current […]
